Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,420.67
-3.53
(-0.04%)
FTSE 250
20,780.29
-93.04
(-0.45%)
AIM
807.55
-2.39
(-0.30%)
GBP/EUR
1.1713
+0.0015
(+0.13%)
GBP/USD
1.2716
+0.0010
(+0.08%)
Bitcoin GBP
55,235.66
+2,355.18
(+4.45%)
Money
What pension research reveals about retirement planning
As the cost of living crisis eases, what steps are you taking to build your pension?
Oramed Pharmaceuticals Inc (OJU1.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
2.1690
+0.0830
(+3.98%)
As of 04:03PM CEST. Market open.
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/08/2021
31/08/2020
Total revenue
674
1,340
2,703
2,703
2,710
Cost of revenue
-
-
-
-
0
Gross profit
-
-
-
-
2,710
Operating expenses
Research development
5,723
8,971
27,639
20,989
10,235
Selling general and administrative
8,474
8,138
15,662
5,937
4,232
Total operating expenses
14,197
17,109
43,301
26,926
14,467
Operating income or loss
-13,523
-15,769
-40,598
-24,223
-11,757
Interest expense
2,629
2,037
0
-
-
Total other income/expenses net
-
16,268
-630
893
-438
Income before tax
10,233
5,088
-37,664
-22,989
-11,511
Income tax expense
-
0
100
-
0
Income from continuing operations
10,233
5,088
-37,764
-22,989
-11,511
Net income
10,456
5,525
-36,561
-22,238
-11,511
Net income available to common shareholders
10,456
5,525
-36,561
-22,238
-11,511
Basic EPS
-0.41
0.14
-0.94
-0.78
-0.56
Diluted EPS
-0.41
0.14
-0.94
-0.78
-0.56
Basic average shares
40,040
40,315
38,998
28,469
20,532
Diluted average shares
40,040
40,567
38,998
28,469
20,532
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.